TY - JOUR
T1 - Evidence of Coxiella burnetii and Bartonella species infections among patients with persistent febrile illness in four low- and middle-income countries
AU - Boodman, Carl
AU - Edouard, Sophie
AU - van Griensven, Johan
AU - Koirala, Kanika Deshpande
AU - Khanal, Basudha
AU - Rijal, Suman
AU - Bhattarai, Narayan Raj
AU - El Safi, Sayda
AU - Phe, Thong
AU - Lim, Kruy
AU - Lutumba, Pascal
AU - Chappuis, François
AU - Yansouni, Cédric P
AU - Barbé, Barbara
AU - van Esbroeck, Marjan
AU - Verdonck, Tine
AU - Boelaert, Marleen
AU - Fournier, Pierre-Édouard
AU - Bottieau, Emmanuel
N1 - Copyright © 2025. Published by Elsevier Ltd.
PY - 2025/5/6
Y1 - 2025/5/6
N2 - OBJECTIVES: This study investigated whether infections due to Coxiella burnetii, Bartonella species or Tropheryma whipplei could be identified among biobanked samples associated with persistent fever in four low- or middle-income countries (LMICs).METHODS: The NIDIAG consortium prospectively investigated in 2013-2014 the etiological spectrum of 1922 patients with persistent febrile illness (fever greater than 7 days) in Cambodia, Nepal, Sudan and the Democratic Republic of Congo (DRC). Our study retrospectively tested serum and blood samples from the 745 patients (38.8%) who remained without an identified cause of fever. Indirect immunofluorescent antibody assays (IFA) were performed (except in the DRC) to assess immunoglobulin response to C. burnetii and Bartonella antigens. DNA extracts from whole blood samples were tested for Coxiella burnetii, Bartonella genus, Bartonella quintana, Bartonella henselae and Tropheryma whipplei by quantitative polymerase chain reaction (qPCR).RESULTS: Evidence of infection with C. burnetii or Bartonella sp. was found in 124 persistent fever cases (16.6%). IFA for IgG to C. burnetii phase I and II antigens identified 59 (7.9%) positive sera: 31/333 (9.3%) from Sudan, 16/278 (5.8%) from Nepal, and 12/54 (22.2%) from Cambodia. Eight individuals had C. burnetii anti-phase I IgG titers ≥ 1:800. Bartonella IFA identified 60 (8.1%) IgG positive sera, with 49/278 (17.6%) positive samples from Nepal, 7/333 (2.1%) from Sudan and 4/54 (7.4%) from Cambodia. One serum from Sudan had anti-Bartonella IgG titers of 1:800. C. burnetii DNA was detected from blood in 3 individuals from Sudan and one individual from the DRC, whereas B. quintana DNA was present in a blood sample from a Nepalese individual. All qPCR tests for T. whipplei were negative.CONCLUSIONS: Direct and indirect evidence of C. burnetii or Bartonella sp. infections was observed in persistent fever cases. Further studies are necessary to elucidate the burden of these diseases in LMICs.
AB - OBJECTIVES: This study investigated whether infections due to Coxiella burnetii, Bartonella species or Tropheryma whipplei could be identified among biobanked samples associated with persistent fever in four low- or middle-income countries (LMICs).METHODS: The NIDIAG consortium prospectively investigated in 2013-2014 the etiological spectrum of 1922 patients with persistent febrile illness (fever greater than 7 days) in Cambodia, Nepal, Sudan and the Democratic Republic of Congo (DRC). Our study retrospectively tested serum and blood samples from the 745 patients (38.8%) who remained without an identified cause of fever. Indirect immunofluorescent antibody assays (IFA) were performed (except in the DRC) to assess immunoglobulin response to C. burnetii and Bartonella antigens. DNA extracts from whole blood samples were tested for Coxiella burnetii, Bartonella genus, Bartonella quintana, Bartonella henselae and Tropheryma whipplei by quantitative polymerase chain reaction (qPCR).RESULTS: Evidence of infection with C. burnetii or Bartonella sp. was found in 124 persistent fever cases (16.6%). IFA for IgG to C. burnetii phase I and II antigens identified 59 (7.9%) positive sera: 31/333 (9.3%) from Sudan, 16/278 (5.8%) from Nepal, and 12/54 (22.2%) from Cambodia. Eight individuals had C. burnetii anti-phase I IgG titers ≥ 1:800. Bartonella IFA identified 60 (8.1%) IgG positive sera, with 49/278 (17.6%) positive samples from Nepal, 7/333 (2.1%) from Sudan and 4/54 (7.4%) from Cambodia. One serum from Sudan had anti-Bartonella IgG titers of 1:800. C. burnetii DNA was detected from blood in 3 individuals from Sudan and one individual from the DRC, whereas B. quintana DNA was present in a blood sample from a Nepalese individual. All qPCR tests for T. whipplei were negative.CONCLUSIONS: Direct and indirect evidence of C. burnetii or Bartonella sp. infections was observed in persistent fever cases. Further studies are necessary to elucidate the burden of these diseases in LMICs.
U2 - 10.1016/j.cmi.2025.04.038
DO - 10.1016/j.cmi.2025.04.038
M3 - Article
C2 - 40339791
SN - 1198-743X
JO - Clinical Microbiology and Infection
JF - Clinical Microbiology and Infection
ER -